Last reviewed · How we verify
NCT06580119
Somatic Psychoeducational Intervention
NA trial testing Somatic Psychoeducational Intervention in Work Related Stress in 30 participants. Completed in 20 February 2025.
20 February 2025
Quick facts
| Lead sponsor | University of Florida |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 15 October 2024 |
| Primary completion | 20 February 2025 |
| Estimated completion | 20 February 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Somatic Psychoeducational Intervention
Conditions studied
- Work Related Stress — all drugs for Work Related Stress →
Sponsor
University of Florida
Who can join
Adults 18 to 89, any sex, with Work Related Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to explore possible benefits and mechanisms through which the Somatic Psychoeducational Intervention can improve health and wellness. The main goals of the study are: * To understand how the participants are doing with regard to their mindfulness, coping behaviors, emotional, physical, and work health, and autonomic reactivity (the degree participants physiologically respond). * To examine regulation of the oxytocinergic system * To investigate whether pre-intervention measures relate to the overall functioning * To determine the 1-week and 1-month post-intervention effects of the Intervention(s) * To identify individual characteristics that influence the effectiveness of the intervention at the 1-week and 1-month post-intervention assessments. Participants will: * complete the online pre-assessment measures regarding how they are doing emotionally and with respect to their work situation. * listen to 15-minutes of calming music and provide pre and post-music salivary samples * complete pre-intervention, post-intervention, 1-week post-intervention, and 1-month post-intervention assessments that involve completion of online measures and collection of saliva samples. * participate in the intervention (which involves 4 hours; the 1-hour classes will be administered over four weeks). Researchers will compare the Intervention Group A (in-person) to Intervention Group B (virtual) to see if the Intervention Group A experiences greater improvements in their health and wellness.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Somatic Psychoeducational Intervention Is Associated with Increased Oxytocin Levels, Improved Autonomic Function, and Reduced Psychological Distress Symptoms in Medical and Social Care Professionals.
Dale LP, Dana AN, Lamont H, Nazarloo P, et al · · 2025 · PMID 41464305 · DOI 10.3390/healthcare13243236
Verify or expand the search:
- PubMed search for NCT06580119
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Somatic Psychoeducational Intervention
Trials testing the same drug.
- NCT05766852 — Potential Benefits of the Somatic Psychoeducational Intervention · NA · completed
Other recruiting trials for Work Related Stress
Currently open trials in the same condition.
- NCT06488547 — Stress and Musculoskeletal Health in Employees · NA · recruiting
- NCT06158204 — Improving Metabolic & Mental Health in Female Healthcare Shift Workers · NA · active not recruiting
- NCT06302764 — Emergency Medical Staff Workload Analysis · recruiting
- NCT06035705 — Patient Acuity in Somatic In-patient Care · recruiting
- NCT06013488 — Character-Strengths Based Coaching For Work-Stress Reduction For Health Workers · NA · recruiting
Other University of Florida trials
Trials by the same sponsor.
- NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
- NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
- NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
- NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
- NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06580119 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Florida
- Last refreshed: 3 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06580119.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing